J Rhinol.  2024 Nov;31(3):145-150. 10.18787/jr.2024.00024.

Outcome of Preoperative Oral Steroids on Patients With Sinonasal Polyposis

• Nehra S
• Choudhury B
• Goyal A
• Soni K
• Sharma V
• Tiwari S

• KMID: 2561496
• DOI: http://doi.org/10.18787/jr.2024.00024

Abstract

Background and Objectives
This study aimed to evaluate whether preoperative oral prednisolone improves the intraoperative parameters and postoperative outcomes over a 3-month period in patients of sinonasal polyposis who undergo functional endoscopic sinus surgery.
Methods
In a triple-blind, randomized controlled study, 43 patients diagnosed with sinonasal polyposis in the Department of ENT, AIIMS, Jodhpur, were enrolled. After obtaining institutional ethics clearance and registering the clinical trial, randomization was conducted to assign participants into experimental and control groups. Preoperatively, patients were assessed using the clinical severity score (Sino-nasal Outcome Test; SNOT-22), radiological severity score (Lund-Mackay score), and endoscopic severity scores (discharge-inflammation-polyp [DIP] score and Lund-Kennedy score). Intraoperative assessment was done using the Perioperative Sinus Endoscopy (POSE) score, the duration of surgery, intraoperative blood loss, and visual analog scale for visual field during surgery and for the ease of disease removal. Postoperatively, at 3 months all the preoperative parameters were reassessed, and, using independent t-test, comparison was made between the two groups.
Results
Twenty-one patients were included in the experimental group (48%), and 22 in the control group (51%). Although the mean duration of surgery in the experimental group was shorter than in the control group, the difference was not statistically significant. Similarly, although the postoperative SNOT-22 score was lower in the experimental group compared to the control group, there was no statistically significant difference in outcomes between the two groups across any of the parameters assessed.
Conclusion
Although the role of oral steroids has been established in the treatment of sinonasal polyposis, our study did not find any significant difference between the group that received oral steroids prior to surgery and the group that received placebo.

Keyword

Oral steroids; CRSwNP; Sinonasal polyposis; Corticosteroids; Systemic steroids

Figure

• 

  Fig. 1. Gender distribution between study groups.

Reference

References

1. Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016; 4(4):565–72.

2. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020; 58(2):82–111.

3. Bhattacharyya N. Assessing the additional disease burden of polyps in chronic rhinosinusitis. Ann Otol Rhinol Laryngol. 2009; 118(3):185–9.

4. Stankiewicz J, Tami T, Truitt T, Atkins J, Winegar B, Cink P, et al. Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum. Int Forum Allergy Rhinol. 2011; 1(1):38–45.

5. Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ. Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngol Head Neck Surg. 2020; 146(9):831–8.

6. Ahern S, Cervin A. Inflammation and endotyping in chronic rhinosinusitis—a paradigm shift. Medicina (Kaunas). 2019; 55(4):95.

7. Thunberg U, Saber A, Söderquist B, Hugosson S. Long-term clinical follow-up of patients with chronic rhinosinusitis. Ann Otol Rhinol Laryngol. 2021; 130(5):504–12.

8. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG. Different types of intranasal steroids for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4(4):CD011993.

9. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010; 125(5):1069–76.e4.

10. Benítez P, Alobid I, de Haro J, Berenguer J, Bernal-Sprekelsen M, Pujols L, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006; 116(5):770–5.

11. Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel perioperative sinus endoscopy (POSE) scoring system. Laryngoscope. 2007; 117(11 Pt 2 Suppl 115):1–28.

12. Durr ML, Pletcher SD, Goldberg AN, Murr AH. A novel sinonasal endoscopy scoring system: the discharge, inflammation, and polyps/edema (DIP) score. Int Forum Allergy Rhinol. 2013; 3(1):66–72.

13. Akbay E, Özgür T, Çokkeser Y. Is there any relationship between the clinical, radiological and histopathologic findings in sinonasal polyposis? Turk Patoloji Derg. 2013; 29(2):127–33.

14. Poetker DM, Jakubowski LA, Lal D, Hwang PH, Wright ED, Smith TL. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013; 3(2):104–20.

15. Rudmik L, Hoy M, Schlosser RJ, Harvey RJ, Welch KC, Lund V, et al. Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013; 3(4):281–98.

16. Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4(4):CD011996.

17. Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005; 115(5):1017–23.

18. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4(4):CD011991.

19. Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4(4):CD011992.

20. Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. 2020; 36(11):1897–911.

21. Berkiten G, Salturk Z, Topaloğlu I. Efficacy of systemic steroid treatment in sinonasal polyposis. J Craniofac Surg. 2013; 24(3):e305–8.

22. Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006; 118(1):128–33.

23. Kowalski ML. Oral and nafsal steroids for nasal polyps. Curr Allergy Asthma Rep. 2011; 11(3):187–8.